Arlo Technologies Insider Sale: 113,912 Shares Sold Under 10b5-1 Plan
Rhea-AI Filing Summary
Arlo Technologies CFO Kurtis Joseph Binder reported the sale of 113,912 shares of Arlo common stock on 08/08/2025. The sales were effected at a weighted average price of $18.558 per share with reported price range $18.26 to $19.05. The Form 4 shows the transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2024.
After the reported sales, the filing shows the reporting person beneficially owns 809,615 shares of Arlo common stock on a direct basis. No derivative securities are reported on this Form 4 and the disclosure provides that full per-price breakdowns will be provided upon request.
Positive
- Sale executed under a Rule 10b5-1 trading plan, adopted 08/29/2024, indicating pre-arranged execution conditions
- Reporting person retains 809,615 shares on a direct basis after the transaction
Negative
- Disposition of 113,912 shares reduces the reporting person’s direct holdings
- Material sale value disclosed (weighted average price $18.558), which may be relevant to investor perception
Insights
TL;DR: Insider sale under a pre-established 10b5-1 plan; proceeds sizing disclosed; remaining direct stake still material at 809,615 shares.
The Form 4 documents a sale of 113,912 shares by the CFO at a weighted average price of $18.558 executed under a Rule 10b5-1 plan adopted 08/29/2024. Because the sale was prearranged under a 10b5-1 plan, it reduces concerns about opportunistic timing, and the filing discloses the price range ($18.26–$19.05) and that more granular price-by-price details are available on request. The remaining direct ownership reported is 809,615 shares, which preserves a meaningful insider stake. Overall, this is a routine management liquidity event rather than a corporate operational development.
TL;DR: Transaction executed under a documented trading plan; disclosure is consistent with Section 16 reporting expectations.
The filing identifies the reporting person as the Chief Financial Officer and indicates the sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 08/29/2024, which provides affirmative defense protection under insider trading rules. The Form 4 includes the weighted average sale price ($18.558), the price range, and post-transaction direct ownership (809,615 shares). The disclosure and signature by attorney-in-fact are in line with routine insider reporting practices; no derivatives or other unusual arrangements are disclosed on this form.